Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview

Clearpoint Neuro

27/02/2023 22:51

* Clearpoint Neuro Inc  CLPT.OQ   CLPT.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 1. 
    * The Solana Beach California-based  company is expected to
report
 a 21.3% increase in revenue to $5.194 million from $4.28
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Clearpoint Neuro
Inc is
for a loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18​, above​ its last closing price of $8.33. ​​​

This summary was machine generated February 27 at 22:51 GMT. 
All figures in US dollars  unless otherwise stated